Следене
Eva Bräunlein
Eva Bräunlein
Други именаEva Braunlein, Eva Braeunlein
Assistenzärztin, Innere Medizin (Hämato-Onkologie), Klinikum rechts der Isar der TU München
Потвърден имейл адрес: tum.de
Заглавие
Позовавания
Позовавания
Година
Direct identification of clinically relevant neoepitopes presented on native human melanoma tissue by mass spectrometry
M Bassani-Sternberg, E Bräunlein, R Klar, T Engleitner, P Sinitcyn, ...
Nature communications 7 (1), 13404, 2016
7072016
Deep learning boosts sensitivity of mass spectrometry-based immunopeptidomics
M Wilhelm, DP Zolg, M Graber, S Gessulat, T Schmidt, K Schnatbaum, ...
Nature communications 12 (1), 3346, 2021
1622021
The CAR-HEMATOTOX score as a prognostic model of toxicity and response in patients receiving BCMA-directed CAR-T for relapsed/refractory multiple myeloma
K Rejeski, DK Hansen, R Bansal, P Sesques, S Ailawadhi, JM Logue, ...
Journal of Hematology & Oncology 16 (1), 88, 2023
622023
Identification and characterization of neoantigens as well as respective immune responses in cancer patients
E Bräunlein, AM Krackhardt
Frontiers in immunology 8, 1702, 2017
562017
T-cell functionality testing is highly relevant to developing novel immuno-tracers monitoring T cells in the context of immunotherapies and revealed CD7 as an attractive target
KE Mayer, S Mall, N Yusufi, D Gosmann, K Steiger, L Russelli, ...
Theranostics 8 (21), 6070, 2018
362018
Proteogenomic analysis reveals RNA as a source for tumor-agnostic neoantigen identification
C Tretter, N de Andrade Krätzig, M Pecoraro, S Lange, P Seifert, ...
Nature Communications 14 (1), 4632, 2023
302023
Key features relevant to select antigens and TCR from the MHC-mismatched repertoire to treat cancer
S Audehm, M Glaser, M Pecoraro, E Bräunlein, S Mall, R Klar, ...
Frontiers in immunology 10, 1485, 2019
142019
Tools to define the melanoma‐associated immunopeptidome
E Bräunlein, AM Krackhardt
Immunology 152 (4), 536-544, 2017
122017
Functional analysis of peripheral and intratumoral neoantigen-specific TCRs identified in a patient with melanoma
E Bräunlein, G Lupoli, F Füchsl, ET Abualrous, N de Andrade Krätzig, ...
Journal for ImmunoTherapy of Cancer 9 (9), 2021
102021
Spatial and temporal plasticity of neoantigen-specific T-cell responses bases on characteristics associated to antigen and TCR
E Bräunlein, G Lupoli, ET Abualrous, N de Andrade Krätzig, D Gosmann, ...
bioRxiv, 2021.02. 02.428777, 2021
32021
High-resolution profiling of neoantigen-specific T cell receptor activation signatures links moderate stimulation patterns to resilience and sustained tumor control
F Füchsl, J Untch, V Kavaka, S Jarosch, C Vogelsang, NA Krätzig, ...
bioRxiv, 2022.09. 23.508529, 2022
12022
Proteogenomic analysis reveals RNA as an important source for tumor-agnostic neoantigen identification correlating with T-cell infiltration
C Tretter, N de Andrade Krätzig, M Pecoraro, S Lange, P Seifert, ...
bioRxiv, 2022.09. 17.508207, 2022
12022
High-resolution profile of neoantigen-specific TCR activation links moderate stimulation to increased resilience of engineered TCR-T cells
F Füchsl, J Untch, V Kavaka, G Zuleger, S Braun, A Schwanzer, S Jarosch, ...
Nature Communications 15 (1), 1-19, 2024
2024
Author Correction: Proteogenomic analysis reveals RNA as a source for tumor-agnostic neoantigen identification
C Tretter, N de Andrade Krätzig, M Pecoraro, S Lange, P Seifert, ...
nature communications 15 (1), 2364, 2024
2024
Proteogenomic analysis reveals RNA as a source for tumor-agnostic neoantigen identification (vol 14, 4632, 2023)
C Tretter, NA Kraetzig, M Pecoraro, S Lange, P Seifert, ...
2024
PROFILING NEOANTIGEN-SPECIFIC T CELL RECEPTOR ACTIVATION: MODERATE STIMULATION PATTERNS LINKED TO INCREASED T CELL RESILIENCE
F Fuechsl, J Untch, V Kavaka, S Jarosch, C Vogelsang, N Kraetzig, ...
HUMAN GENE THERAPY 34 (21-22), A17-A17, 2023
2023
MASS SPECTROMETRY-BASED IMMUNOPEPTIDOMICS APPROACH REVEALS IMMUNOGENICITY OF A POTENTIAL NEOANTIGEN IN THE MULTIPLE MYELOMA CELL LINE JJN3
G Zuleger, S Lutzenberger, CY Lee, N Kraetzig, D Andrade, C Tretter, ...
HUMAN GENE THERAPY 34 (21-22), A44-A45, 2023
2023
P09. 17 High-resolution of neoantigen-specific T cell receptor activation patterns–moderate stimulation predicts sustained anti-tumor-response
F Füchsl, J Untch, V Kavaka, S Jarosch, C Vogelsang, ...
Journal for ImmunoTherapy of Cancer 10 (Suppl 1), 2022
2022
DISCOVERING AND ASSESSING TRANSCRIPTOMIC SIGNATURES OF ANTIGEN-DEPENDENT ACTIVATION IN NEOANTIGEN-SPECIFIC TCRS ON A SINGLE-CELL LEVEL
J Untch, E Braeunlein, F Fuechsl, S Jarosch, N Kraetzig, O Baranov, ...
2022
Identifizierung von Neoantigenen für immuntherapeutische Ansätze
E Bräunlein, AM Krackhardt
Der Onkologe 27 (11), 1109-1113, 2021
2021
Системата не може да изпълни операцията сега. Опитайте отново по-късно.
Статии 1–20